Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Interventional × Potassium Iodide × Clear all

Phase

Status

Terminated 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neuroblastoma 1

Interventions

Cyclophosphamide 1282 Cisplatin 1207 Paclitaxel 1134 Radiotherapy 1113 Carboplatin 1074 Gemcitabine 1055 Docetaxel 962 Bevacizumab 895 Fluorouracil 775 Doxorubicin 684 Dexamethasone 648 Capecitabine 645 Rituximab 623 Oxaliplatin 603 Etoposide 584 pembrolizumab 554 Irinotecan 554 Filgrastim 541 Leucovorin 506 Cytarabine 505 Nivolumab 459 Vincristine 440 Prednisone 407 Bortezomib 404 Cetuximab 402 Erlotinib Hydrochloride 394 Trastuzumab 383 Methotrexate 366 Lenalidomide 362 Pemetrexed 358

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03332667 2025-04-16

MIBG With Dinutuximab +/- Vorinostat

New Approaches to Neuroblastoma Therapy Consortium

Phase 1 Completed

45 enrolled 16 charts

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡